Search results Search for: Search Refine your results by duration: Any Under 5 mins Under 20 mins Over 20 mins Sort by: Relevance Views Date Building the Lab of the Future Through AI, ML & Cultural Change Christos Varsakelis at The Janssen Pharmaceutical Companies of Johnson & Johnson Production of data is a costly business for Biopharma, always under scrutiny, and this is highly unlikely to change. On the other hand, AI/ML is de f... 2 days ago | 46 mins Adaptation of the analytical control strategy of a commercial vaccine... Jean-Francois Dierick at GSK Full Title: Adaptation of the analytical control strategy of a commercial vaccine using the principles of QbD. Challenges, lessons learned and improve... March 30, 2023 2:00pm End-to-End Single-Use Manufacturing at Pilot Plant for Early Development... Agnieszka Önder , DS Operations Pilot Plant Leiden at The Janssen Pharmaceutical Companies of Johnson & Johnson Full title: End-to-End Single-Use Manufacturing at Pilot Plant for Early Development Clinical Material The Single Use Item within the Pharmaceutical ... 2 weeks ago | 26 mins Burkholderia Cepacia Complex and Aqueous Non-Sterile Drug Manufacture... Dr John Metcalfe, Senior Pharmaceutical Quality Assessor at FDA and Dr. Doug Botkin at Charles River Laboratories Full title: Burkholderia Cepacia Complex and Aqueous Non-Sterile Drug Manufacture: Updates from a CDER Microbiologist's Perspective During this webin... April 19, 2023 2:00pm Trends and Future of Pharmaceutical Continuous Manufacturing Lawrence De Belder, at Pharmatech Associates, Inc. and Jan Vogeleer at Fette Compacting In this webinar, Lawrence De Belder will give an overview of the history, present, and expected future of continuous manufacturing for drug product, d... April 27, 2023 2:00pm Advanced digitalization plan for AstraZeneca's CDC line Presented by Melanie Dumarey, Product and process design engineer (associate principal scientist) at AstraZeneca Presented by Presented by Melanie Dumarey, Product and process design engineer (associate principal scientist) at AstraZeneca 1 week ago | 47 mins Points to consider when defining a microbial control strategy... Friedrich von Wintzingerode, PhD, QC Lead iNeST Project (individualized Neoantigen Specific Therapy) Full title: Points to consider when defining a microbial control strategy for individualized ATMPs How are individualized ATMPs different from tradit... April 5, 2023 5:00pm LESSONS & BENEFITS GAINED FROM THE IMPLEMENTATION OF AN AUTOMATED BET SOLUTION Dennis Wong Global at AstraZeneca Liverpool UK and Jordi Iglesias at Charles River The webinar will provide an insight into a global deployment program for an automated solution for Endotoxin testing. A range of implementation aspect... 2 weeks ago | 74 mins Platform Technology To Speed Up CMC Process Dr H. Fai Poon, President, QuaCell Biotech Ltd The commercial success of monoclonal antibodies has made biologics become attractive to pharmaceutical companies . The approval pathway is often requi... 1 week ago | 32 mins Ruggedness and Robustness in Nitrosamine Analysis from Pharmaceutical Elastomers Jason Creasey, Managing Director at Maven E&L Ltd This webinar will outline elements to consider in the ruggedness and robustness of methods of analysis for nitrosamine from elastomers used in pharma.... May 23, 2023 2:00pm Load more
